Top Social Impact Companies in NYC, NY (653)

Strong Revenue Growth: Revenue is rising at double-digit rates across multiple periods, including about 26% in 2025 and 22% year over year in Q2 2026. Multi-year gains in direct revenue alongside an expanding payer base reinforce the trajectory.

Market Expansion: International rollout across Europe and Latin America is accelerating, with European expansion‑market revenue up 86% year over year in Q2 2026 and new country launches continuing. Global monthly active users also increased 13% year over year, supporting the geographic scaling.

Resilient & Sustainable Growth: Growth spans users, payers, and revenue, with three successive years of higher direct revenue and a rising paying‑user base. These concurrent trends indicate momentum that extends beyond price mix alone.

Market Expansion: Operations span all 50 states and Washington, D.C., with coverage reported across 100+ health plans and expansion into Medicare Advantage and Medicaid. This broadened payer and geographic footprint increases addressable demand and distribution leverage.

Product Line Growth: Offerings have expanded beyond matching into EHR, AI‑assisted notes, telehealth, billing, integrated‑care referrals, and a patient app. These additions deepen provider engagement and create more touchpoints for utilization and scale.

Strong Revenue Growth: Annual revenue is described as having more than doubled over a recent 12‑month period in 2024, indicating accelerating commercial momentum. While later‑period figures are not disclosed, the earlier surge aligns with rapid operating scale increases.

Strong Hiring & Retention: Hiring is active across sales, account management, product, operations, HR, and compliance, with current postings and updates indicating continued team expansion in 2026. Reported headcount has increased over recent years, pointing to investment in both go-to-market and delivery capacity.

Market Expansion: Operations span numerous U.S. cities and European hubs beyond the company’s original New York base. Materials also describe global retrieval capabilities supported by partners.

Product Line Growth: Services have expanded to include retrievals for laptops, phones, tablets, monitors, and other equipment. A software platform for asset tracking, workflow automation, and compliance reporting broadens the offering further.

Investor Backing & Capital Strength: Funding activity indicates renewed investor support, with $10 million raised in July 2026 toward a planned $32 million offering following a $28.1 million round in 2023. Cumulatively reported capital of roughly $52.9 million provides resources for rebuilding and expansion.

Market Expansion: Multi-state operations spanning Florida, Michigan, Ohio, Virginia, and Washington and a reported 45,000 attributed lives point to meaningful commercial reach. Company materials describe active launches and team-building across these markets.

Strategic Partnerships: Payer-oriented relationships, including a Carelon collaboration, align the model with health plans and community providers. These arrangements create distribution pathways to hard-to-reach populations within managed-care programs.

Strong Revenue Growth: Revenue is reported to have risen year over year in Q2 2026 to $71.1 million, with the prior quarter also showing strong year-over-year gains. Growth outpaced subscriber increases, supported by higher monthly revenue per subscriber.

Profitability: The business is described as profitable, with Axios noting profitability in 2023 and subsequent reporting showing positive operating profit in Q2 2026. These indications point to a model capable of generating earnings alongside scale.

Strategic Partnerships: Embedded distribution such as the 2026 Experian pilot reportedly became one of the largest sources of new cash‑advance volume within months. Additional integrations, including Engine by MoneyLion, are cited as materially lifting application flow and monetization.

Strong Revenue Growth: Feedback suggests ARR reportedly doubled year over year and was expected to at least double again, signaling rapid top-line momentum. While company-reported rather than audited, this is the clearest quantitative indicator provided.

Strong Market Position & Advantage: Feedback suggests adoption across more than 5,000 childcare programs and nationwide reach indicate meaningful scale and positioning. The September 2026 acquisition by Procare further underscores strategic relevance within the category.

Innovation-Driven Growth: Feedback suggests expansion from communications into billing, payroll, enrollment, reporting, subsidy management, and AI tools is broadening the platform’s value proposition. Frequent releases and a childcare-focused AI assistant point to ongoing product-led growth.

Strong Revenue Growth: Reported annual revenue reached $100 million in 2025 and annual recurring revenue surpassed $200 million by late 2026, indicating accelerating top-line momentum. Growth was characterized as rapid during 2026, reflecting increased customer demand and scale.

Market Expansion: The company entered Canada with UnKibble and stepped up brand investment, including a multimillion-dollar TV and out-of-home campaign. These moves expand geographic reach and aim to scale acquisition beyond prior channels.

Product Line Growth: Offerings broadened beyond fresh meals and UnKibble into supplements and the PupGum dental-chew brand, which reportedly reached eight-figure recurring revenue within months of launch. Added categories and dedicated leadership signal a push to build a wider pet wellness platform.

Investor Backing & Capital Strength: Ownership by KIRKBI since 2022 provides long-term capital support and strategic backing for expansion across products and markets. Company and owner communications position this as a foundation for scaling domestically and internationally.

Product Line Growth: Expanded reading scaffolds, cross-product search, additional interactive activities, LMS integrations, and AI-assisted grading in BrainPOP Science (used to grade over 42 million assignments with 230,000+ educators monthly) indicate active product investment and adoption. These enhancements suggest continued momentum in feature development and classroom utility.

Strong Market Position & Advantage: Presence in more than two-thirds of U.S. school districts and an estimated 25 million students reached annually underscore entrenched access to the K–12 market. KIRKBI also reported more than 2 million monthly student users across 28,000+ U.S. schools in 2024, highlighting substantial existing scale.

Investor Backing & Capital Strength: A $30 million Series B led by Andreessen Horowitz in February 2025 brought total funding to $50 million, with Axios independently reporting the round. This capital base supports continued hiring and expansion across product and go-to-market functions.

Market Expansion: The company reports expanding from behavioral health/ABA into physical therapy, ENT/allergy, and broader specialty care, and now serves 500+ providers across all 50 states. Year-end 2025 metrics also cite 81.8% growth in clinics and 163% growth in patients, and a 2026 acquisition added workflow automation expertise.

Innovation-Driven Growth: Platform capabilities are built on more than $2.5 billion in claims data with millions of claims processed, and reported a 12.3% year-over-year improvement in first-pass paid rate. These data- and automation-led workflows underpin scaling of claims across a nationwide footprint.

Product Line Growth: Feedback suggests newer offerings like Pharma Direct and subscriptions are expanding rapidly, indicating momentum beyond the legacy prescription-discount model.

Strategic Partnerships: Feedback suggests deepening relationships with pharmaceutical manufacturers are driving strong growth in Pharma Direct and expanding medication-access programs.

Healthy Cash Flow: Feedback suggests operating cash flow was strong in recent periods, even as total revenue was near flat and segment performance was mixed.

Strong Revenue Growth: Estimated annualized net revenue rose from about $800 million in 2023 to roughly $1.2 billion in 2024, indicating substantial scaling. Earlier reporting also pointed to 2023 sales surpassing $800 million, reinforcing a multi‑year growth trajectory.

Profitability: Reporting indicates the business generated more than $10 million in monthly profits in 2025, suggesting growth paired with positive economics. While the company is private, these signals point to earnings strength alongside scale.

Market Expansion: Launching on Walmart.com in April 2026—and later availability on Amazon.com—extended distribution beyond the company’s own subscription channel. The 2026 acquisition of Woof further broadened its commercial footprint into adjacent pet‑care categories.

Market Expansion: The platform’s reported research-site network scaled from hundreds in 2022 to 6,000+ sites across 50+ countries, alongside a broader base of 25+ sponsors. Feedback suggests recent partnerships helped extend reach to additional site networks.

Product Line Growth: Inato moved beyond its original marketplace into AI-powered patient pre-screening and AI site-selection, with ongoing workflow integrations. These additions indicate continued investment in broader clinical-trial capabilities.

Strategic Partnerships: Collaborations such as the RealTime eClinical Solutions agreement and integrations with CRIO and other providers are described as expanding distribution and deepening ecosystem ties. Feedback suggests these relationships open pathways to thousands of affiliated sites and embed the platform more fully in site workflows.

Market Expansion: Service availability is described across all 50 states with new local launches and roles dedicated to opening regional provider partnerships. This points to broadening geographic reach and distribution through healthcare and senior-care channels.

Product Line Growth: The platform has expanded beyond therapy to include healthcare advocacy, wellness classes, and AI-enabled care agents. These additions indicate a widening offering to address aging-related needs.

Strong Hiring & Retention: Active recruitment spans engineering, operations, analytics, revenue-cycle management, and provider-partnerships to scale care delivery. Such hiring momentum suggests investment in internal capacity to support larger patient and provider volumes.

Strong Revenue Growth: Feedback suggests revenue expanded rapidly, highlighted by a first-place ranking in the FT’s 2026 Americas’ Fastest-Growing Companies based on 2021–2024 growth and a reported $617.4M in 2024 revenue. Additional signals include reported surges in appointments and broader commercial activity across 2025–2026.

Investor Backing & Capital Strength: Feedback suggests substantial access to capital, including a $150M Series D in March 2026 and cumulative funding of about $328M. This capital appears to support expansion into insurers, employers, and health-system partnerships.

Market Expansion: Feedback suggests the company expanded distribution via 125+ health-plan partners (later 135), employer benefits, and health-system integrations. These channels appear to broaden reach beyond direct patient acquisition.